246 related articles for article (PubMed ID: 23037991)
1. Capsaicin for neuropathic pain: linking traditional medicine and molecular biology.
Haanpää M; Treede RD
Eur Neurol; 2012; 68(5):264-75. PubMed ID: 23037991
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
[TBL] [Abstract][Full Text] [Related]
3. Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief.
Remadevi R; Szallisi A
IDrugs; 2008 Feb; 11(2):120-32. PubMed ID: 18240098
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
5. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Maihofner C; Heskamp ML
Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
[TBL] [Abstract][Full Text] [Related]
6. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
Jones VM; Moore KA; Peterson DM
J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
[TBL] [Abstract][Full Text] [Related]
9. Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.
Campbell JN; Stevens R; Hanson P; Connolly J; Meske DS; Chung MK; Lascelles BDX
Molecules; 2021 Feb; 26(4):. PubMed ID: 33546181
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
Blair HA
Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
[TBL] [Abstract][Full Text] [Related]
11. Capsaicin-based therapies for pain control.
Smith H; Brooks JR
Prog Drug Res; 2014; 68():129-46. PubMed ID: 24941667
[TBL] [Abstract][Full Text] [Related]
12. Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.
Szolcsányi J; Pintér E
Expert Opin Ther Targets; 2013 Jun; 17(6):641-57. PubMed ID: 23421411
[TBL] [Abstract][Full Text] [Related]
13. [TRPV1 in neuropathic pain: from animal models to therapeutical prospects].
Danigo A; Magy L; Demiot C
Med Sci (Paris); 2013; 29(6-7):597-606. PubMed ID: 23859514
[TBL] [Abstract][Full Text] [Related]
14. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
15. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.
Noto C; Pappagallo M; Szallasi A
Curr Opin Investig Drugs; 2009 Jul; 10(7):702-10. PubMed ID: 19579176
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.
Ann J; Kim HS; Thorat SA; Kim H; Ha HJ; Choi K; Kim YH; Kim M; Hwang SW; Pearce LV; Esch TE; Turcios NA; Blumberg PM; Lee J
J Med Chem; 2020 Jan; 63(1):418-424. PubMed ID: 31702924
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin 8% dermal patch in clinical practice: an expert opinion.
Bonezzi C; Costantini A; Cruccu G; Fornasari DMM; Guardamagna V; Palmieri V; Polati E; Zini P; Dickenson AH
Expert Opin Pharmacother; 2020 Aug; 21(11):1377-1387. PubMed ID: 32511032
[TBL] [Abstract][Full Text] [Related]
18. Targeting TRPV1 for pain relief: limits, losers and laurels.
Szallasi A; Sheta M
Expert Opin Investig Drugs; 2012 Sep; 21(9):1351-69. PubMed ID: 22780443
[TBL] [Abstract][Full Text] [Related]
19. Zucapsaicin for the treatment of neuropathic pain.
Sałat K; Jakubowska A; Kulig K
Expert Opin Investig Drugs; 2014 Oct; 23(10):1433-40. PubMed ID: 25171227
[TBL] [Abstract][Full Text] [Related]
20. Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection.
Kim SM; Kim J; Kim E; Hwang SJ; Shin HK; Lee SE
Neurosci Lett; 2008 Mar; 433(3):199-204. PubMed ID: 18242851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
